| Basics |
| Company: |
BioAge Labs, Inc. |
| IPO Date: |
September 26, 2024 |
| Sector: |
Healthcare |
| Industry: |
Drug Manufacturers |
| Market Cap: |
$161.32M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.60 | 4.62%
|
| Avg Daily Range (30 D): |
$0.15 | 3.15%
|
| Avg Daily Range (90 D): |
$0.51 | 4.44%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.55M |
| Avg Daily Volume (30 D): |
.23M |
| Avg Daily Volume (90 D): |
.51M |
| Trade Size |
| Avg Trade Size (Sh.): |
113 |
| Avg Trade Size (Sh.) (30 D): |
98 |
| Avg Trade Size (Sh.) (90 D): |
112 |
| Institutional Trades |
| Total Inst.Trades: |
36 |
| Avg Inst. Trade: |
$1.6M |
| Avg Inst. Trade (30 D): |
$1.15M |
| Avg Inst. Trade (90 D): |
$1.3M |
| Avg Inst. Trade Volume: |
.14M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.19M |
| Avg Closing Trade (30 D): |
$.64M |
| Avg Closing Trade (90 D): |
$2.94M |
| Avg Closing Volume: |
240.99K |
|
|
|
|
| News |
Feb 22, 2025 @ 12:16 PM
BIOA CLASS ACTION DEADLINE: BioAge Labs Investors ...
Source: N/A
|
Feb 21, 2025 @ 5:00 PM
Deadline Alert: BioAge Labs, Inc. (BIOA) Investors...
Source: N/A
|
Feb 21, 2025 @ 1:39 AM
BIOA SHAREHOLDER ALERT: Kessler Topaz Meltzer & C...
Source: N/A
|
Feb 21, 2025 @ 12:28 AM
ROSEN, NATIONAL TRIAL LAWYERS, Encourages BioAge L...
Source: Rosen, National Trial Lawyers
|
Feb 19, 2025 @ 9:00 PM
BIOA INVESTOR ALERT: Bronstein, Gewirtz & Grossman...
Source: Bronstein, Gewirtz & Grossman Llc
|
| Financials |
| |
TTM |
Q3 2024 |
Q2 2024 |
|
Basic EPS
|
|
$-6.7
|
|
|
Diluted EPS
|
|
$-6.7
|
|
|
Revenue
|
$
|
$ M
|
$
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$
|
$ -23.41M
|
$ -13.58M
|
|
Operating Income / Loss
|
$
|
$ -24.75M
|
$
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$
|
$
|
$
|
|
PE Ratio
|
|
|
|
|
